156 related articles for article (PubMed ID: 17672952)
1. [Functions of spleen tyrosine kinase (Syk) gene and its correlation to neoplasms].
Wang HY; Zhang ZX
Ai Zheng; 2007 May; 26(5):555-60. PubMed ID: 17672952
[TBL] [Abstract][Full Text] [Related]
2. The Syk tyrosine kinase: a new negative regulator in tumor growth and progression.
Coopman PJ; Mueller SC
Cancer Lett; 2006 Sep; 241(2):159-73. PubMed ID: 16442709
[TBL] [Abstract][Full Text] [Related]
3. Calling in SYK: SYK's dual role as a tumor promoter and tumor suppressor in cancer.
Krisenko MO; Geahlen RL
Biochim Biophys Acta; 2015 Jan; 1853(1):254-63. PubMed ID: 25447675
[TBL] [Abstract][Full Text] [Related]
4. Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.
Wang L; Devarajan E; He J; Reddy SP; Dai JL
Cancer Res; 2005 Nov; 65(22):10289-97. PubMed ID: 16288017
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.
Wang L; Duke L; Zhang PS; Arlinghaus RB; Symmans WF; Sahin A; Mendez R; Dai JL
Cancer Res; 2003 Aug; 63(15):4724-30. PubMed ID: 12907655
[TBL] [Abstract][Full Text] [Related]
6. Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest.
Bailet O; Fenouille N; Abbe P; Robert G; Rocchi S; Gonthier N; Denoyelle C; Ticchioni M; Ortonne JP; Ballotti R; Deckert M; Tartare-Deckert S
Cancer Res; 2009 Apr; 69(7):2748-56. PubMed ID: 19293188
[TBL] [Abstract][Full Text] [Related]
7. Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase.
Li J; Sidell N
Int J Cancer; 2005 Oct; 117(1):14-20. PubMed ID: 15880583
[TBL] [Abstract][Full Text] [Related]
8. Identification of BCAR-1 as a new substrate of Syk tyrosine kinase through a determination of amino acid sequence preferences surrounding the substrate tyrosine residue.
Kim JY; Huh K; Jung R; Kim TJ
Immunol Lett; 2011 Mar; 135(1-2):151-7. PubMed ID: 21047529
[TBL] [Abstract][Full Text] [Related]
9. Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma.
Yuan Y; Wang J; Li J; Wang L; Li M; Yang Z; Zhang C; Dai JL
Clin Cancer Res; 2006 Nov; 12(22):6687-95. PubMed ID: 17121887
[TBL] [Abstract][Full Text] [Related]
10. Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck.
Luangdilok S; Box C; Patterson L; Court W; Harrington K; Pitkin L; Rhŷs-Evans P; O-charoenrat P; Eccles S
Cancer Res; 2007 Aug; 67(16):7907-16. PubMed ID: 17699797
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine kinase, syk: a key player in phagocytic cells.
Tohyama Y; Yamamura H
J Biochem; 2009 Mar; 145(3):267-73. PubMed ID: 19124456
[TBL] [Abstract][Full Text] [Related]
13. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
Chen XL; Li L; Zhang YJ
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
[TBL] [Abstract][Full Text] [Related]
14. Expression and methylation status of the Syk gene in cervical carcinoma.
Zhao S; Sun G; Tony PW; Ma D; Zhao C
Arch Gynecol Obstet; 2011 May; 283(5):1113-9. PubMed ID: 20563729
[TBL] [Abstract][Full Text] [Related]
15. Spleen tyrosine kinase as a novel candidate tumor suppressor gene for human oral squamous cell carcinoma.
Ogane S; Onda T; Takano N; Yajima T; Uchiyama T; Shibahara T
Int J Cancer; 2009 Jun; 124(11):2651-7. PubMed ID: 19195024
[TBL] [Abstract][Full Text] [Related]
16. [Hypermethylation of syk gene in promoter region is associated with oncogenesis, metastasis of breast carcinoma].
Ding YB; Wu ZY; Wang S; Zha XM; Zheng W; Liu XA; Fan P
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):290-3. PubMed ID: 15059510
[TBL] [Abstract][Full Text] [Related]
17. Steady state kinetics of spleen tyrosine kinase investigated by a real time fluorescence assay.
Papp E; Tse JK; Ho H; Wang S; Shaw D; Lee S; Barnett J; Swinney DC; Bradshaw JM
Biochemistry; 2007 Dec; 46(51):15103-14. PubMed ID: 18052078
[TBL] [Abstract][Full Text] [Related]
18. [Biological mechanism of full-length form of spleen tyrosine kinase regulating gene transcription in breast cancer cells].
Wang L; Hu Y; Yang ZL; Song XM; Wang JP
Ai Zheng; 2007 May; 26(5):469-72. PubMed ID: 17672934
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation leads to silencing of the SYK gene in human breast cancer.
Yuan Y; Mendez R; Sahin A; Dai JL
Cancer Res; 2001 Jul; 61(14):5558-61. PubMed ID: 11454707
[TBL] [Abstract][Full Text] [Related]
20. Spleen tyrosine kinase suppresses osteoblastic differentiation through MAPK and PKCα.
Yoshida K; Higuchi C; Nakura A; Yoshikawa H
Biochem Biophys Res Commun; 2011 Aug; 411(4):774-9. PubMed ID: 21782794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]